找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Alternative Approaches to Human Blood Resources in Clinical Practice; Proceedings of the T C. Th. Smit Sibinga,P. C. Das,J. C. Fratantoni C

[復(fù)制鏈接]
樓主: mortality
21#
發(fā)表于 2025-3-25 04:40:02 | 只看該作者
https://doi.org/10.1007/978-3-662-06599-0 a clear clinical question and then relevant clinical articles will be searched for, critically appraised (evaluated) for validity and usefulness and the results are finally implemented in clinical practice [1–4].
22#
發(fā)表于 2025-3-25 10:31:06 | 只看該作者
23#
發(fā)表于 2025-3-25 11:41:29 | 只看該作者
Die Kollapstherapie der Lungentuberkulose,(or expected) blood loss occurred during surgery, the patient would be in less danger of suffering deficient O. delivery to tissue. Guidelines for the transfusion of blood or packed red cells in the face of severe blood loss have been less well defined.
24#
發(fā)表于 2025-3-25 16:59:17 | 只看該作者
The Role of O2 Transport in the Development of the Transfusion Trigger(or expected) blood loss occurred during surgery, the patient would be in less danger of suffering deficient O. delivery to tissue. Guidelines for the transfusion of blood or packed red cells in the face of severe blood loss have been less well defined.
25#
發(fā)表于 2025-3-25 20:39:53 | 只看該作者
26#
發(fā)表于 2025-3-26 00:46:28 | 只看該作者
Evidence-Based Transfusion Medicine or the Need to Evaluate Clinical Outcome a clear clinical question and then relevant clinical articles will be searched for, critically appraised (evaluated) for validity and usefulness and the results are finally implemented in clinical practice [1–4].
27#
發(fā)表于 2025-3-26 04:44:57 | 只看該作者
The Development of Synthocytes?, a Novel Platelet Substituteet transfusion include a reduced risk of blood borne virus transmission, no risk of alloimmunogenic reactions, an increased shelf life and therefore a more cost effective, more easily managed therapy.
28#
發(fā)表于 2025-3-26 09:09:57 | 只看該作者
Conference proceedings 1998development of alternative approaches in thisrapidly developing area. In clinical medicine conventional blood andits components are used in supportive therapies dependent on thechoice of apparent uncritical trigger factors. A compounding factor isdepth of prospective clinical trials for evidence. Su
29#
發(fā)表于 2025-3-26 15:59:38 | 只看該作者
30#
發(fā)表于 2025-3-26 17:08:21 | 只看該作者
Warum es diese Patientenleitlinie gibt,perative haemoglobin level or platelet transfusion level, the preferences of opinion leaders in the local clinical community [7], the availability of a transfusion committee with an authoritative surveillance system, variations in supply or in local or regional risks or public perceptions of those risks.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 18:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
峨眉山市| 峡江县| 东乌| 米泉市| 盐池县| 区。| 辰溪县| 萨迦县| 花垣县| 富阳市| 福建省| 称多县| 衡阳县| 延庆县| 嘉峪关市| 安岳县| 湖北省| 镇原县| 南乐县| 浦城县| 拉萨市| 定州市| 巩义市| 泾源县| 公主岭市| 南川市| 恭城| 长春市| 德江县| 车险| 金山区| 武陟县| 梁平县| 甘德县| 南皮县| 泸西县| 怀安县| 响水县| 怀远县| 瑞昌市| 曲松县|